Results 41 to 50 of about 626 (166)

Recurrence and massive extraocular extension of choroidal malignant melanoma after vitrectomy and endoresection

Indian Journal of Ophthalmology, 2014
Vitrectomy and endoresection is an alternative to enucleation for the treatment of large malignant choroidal melanoma. We report a rare case of extensive recurrence of choroidal malignant melanoma with extraocular extension 11 years after surgical ...
Mehdi Modarres, Asgari Rezanejad, Khalil Ghasemi Falavarjani   +2 more
doaj   +1 more source

Widening use of dexamethasone implant for the treatment of macular edema [PDF]

, 2017
Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis.
Avitabile T., Bonfiglio V., Fallico M., Fichera S., Longo A., Macchi I., Pizzo A., Rapisarda C., Reibaldi M., Russo A.   +9 more
core   +2 more sources

Surgical Treatment in Uveal Tumors

Türk Oftalmoloji Dergisi, 2014
Surgical treatment in uveal tumors can be done via iridectomy, partial lamellar sclerouvectomy (PLSU) and endoresection. Iridectomy is done in iris tumors without angle and ciliary body involvement.
Kaan Gündüz
doaj   +1 more source

Exoresection and endoresection for uveal melanoma

Middle East African Journal of Ophthalmology, 2010
Surgical resection of uveal melanomas is an alternative eye-salvaging approach to the more commonly used irradiation techniques. There are two surgical resection techniques: Transscleral resection or "Exoresection" via a partial lamellar sclerouvectomy and "Endoresection" via a pars plana vitrectomy.
Gündüz, Kaan, Bechrakis, Nikolaos E.
openaire   +3 more sources

Small High-Risk Uveal Melanomas Have a Lower Mortality Rate [PDF]

, 2021
Our aim was to determine whether size impacts on the difference in metastatic mortality of genetically high-risk (monosomy 3) uveal melanomas (UM). We undertook a retrospective analysis of data from a patient cohort with genetically characterized UM. All
Coupland, Sarah E, Damato, Bertil E, Eleuteri, Antonio, Groenewald, Carl, Heimann, Heinrich, Hussain, Rumana N, Kalirai, Helen, Taktak, Azzam FG   +7 more
core   +1 more source

Personalized treatment of uveal melanoma [PDF]

, 2012
Personalized treatment of uveal melanoma involves the tailoring of all aspects of care to the condition, needs, wishes, and fears of the patient, taking account of the individual's circumstances.
Damato, B, Heimann, H
core   +1 more source

Malignant Epiretinal Membrane After Proton Beam Radiation of Ciliary Body Melanoma [PDF]

, 2023
Purpose: To report the development of malignant epiretinal membrane after radiation of ciliary body melanoma.Case report: A 65-year-old woman was referred for evaluation of a ciliary body tumor in her right eye.
Bolling, James, Dorairaj, Syril, Mashayekhi, Arman, Wagner, Isabella, Wu, Kevin, Yousaf, Mohammad   +5 more
core   +2 more sources

Vasoproliferative retinal tumors. Current approach to treatment Relevance. Vasoproliferative retinal tumor is a rare acquired disease.

Офтальмохирургия, 2021
The exact pathogenesis of vasoproliferative tumors remains completely unknown, and it has long been assumed that their development is a reactive process with the proliferation of glial cells and blood vessels.
Yu. B. Gorodetskaya, A. A. Yarovoy, I. M. Gorshkov, R. A. Loginov   +3 more
doaj   +1 more source

Preliminary results of proton radiotherapy for choroidal melanoma : the Kraków experience [PDF]

, 2014
AIM OF THE STUDY: The objective of the study was to present the preliminary results of proton radiotherapy as a method for treating 15 patients with choroidal melanoma.
Markiewicz, Anna, Pluta, Elżbieta, Romanowska-Dixon, Bożena, Sas-Korczyńska, Beata   +3 more
core   +1 more source

Outcome Measures of New Technologies in Uveal Melanoma Review from the European Vision Institute Special Interest Focus Group Meeting [PDF]

, 2023
Uveal melanoma UM is the most common primary intraocular tumor in adults. New diagnostic procedures and basic science discoveries continue to change our patient management paradigms.
Beenakker, J. W.M., Brouwer, N.J., Chau, C., Coupland, S.E., Damato, B.E., Fiorentzis, M., Heimann, H., Heufelder, J., Jager, M.J., Joussen, A.M., Kiilgaard, J.F., Kivelä, T.T., Piperno Neumann, S., Rantala, E.S., Romanovska Dixon, B., Scholl, H.P.N., Shields, C.L., Wheeler Schilling, T., Willerding, G.D.   +18 more
core   +2 more sources